Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.38

-9.0%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	12/13/2001 4:28:48 PM
From: Ian@SI	Read Replies (1) of 52153

Here's an ouch!!!! Perhaps it belongs on the firesale thread... Now trading near $10.50 16:24 ET Pharmacyclics (PCYC) 21.70 -1.33: Announces top-line results of its Phase III clinical trial of lead product, Xcytrin (motexafin gadolinium) Injection, for the potential treatment of brain metastases; the study did not achieve statistical significance on the primary endpoints.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next